Page 1 | Search Results | Anesthesiology | American Society of Anesthesiologists

1-5 of 5

Sort by

Sort Order Select

Articles

Protamine Dosing for Heparin Reversal after Cardiopulmonary Bypass: A Double-blinded Prospective Randomized Control Trial Comparing Two Strategies

Pankaj Jain, M.D., Alejandra Silva-De Las Salas, M.D., Kabir Bedi, B.S., Joseph Lamelas, M.D., Richard H. Epstein, M.D., F.A.S.A., Michael Fabbro, II, D.O.

Anesthesiology. November 2024: 10.1097/ALN.0000000000005256

https://doi.org/10.1097/ALN.0000000000005256

Published: November 2024

View article

Articles

Anticoagulation Monitoring for Perioperative Physicians

Cheryl L. Maier, M.D., Ph.D., Roman M. Sniecinski, M.D., M.Sc.

Anesthesiology. October 2021: 135(4):738–748

https://doi.org/10.1097/ALN.0000000000003903

Published: October 2021

View article

Articles

Factor XII Deficiency and Cardiopulmonary Bypass : Use of a Novel Modification of the Activated Clotting Time to Monitor Anticoagulation

Mark A. Gerhardt, MD, PhD, Charles S. Greenberg, MD, Thomas F. Slaughter, MD, Mark Stafford Smith, MD, CM, FRCPC

Anesthesiology. October 1997: 87(4):990–992

https://doi.org/10.1097/00000542-199710000-00038

Published: October 1997

View article

Articles

Normal Activated Clotting Time Despite Adequate Anticoagulation with Ancrod in a Patient with Heparin-associated Thrombocytopenia and Thrombosis Undergoing Cardiopulmonary Bypass

Burkhard F. Spiekermann, M.D., Carol L. Lake, M.D., George F. Rich, M.D., Ph.D., John E. Humphries, M.D.

Anesthesiology. March 1994: 80(3):686–688

https://doi.org/10.1097/00000542-199403000-00029

Published: March 1994

View article

Articles

ACTIVATED CLOTTING TIME MEASUREMENTS: HOW MUCH WASTE SHOULD BE DRAWN FROM A CONTINUOUSLY FLUSHED-HEPARINIZED LINE TO INSURE ACCURATE RESULTS?

L. D. Wade, M. S., H. W. Weiss, M.D., W. J. McCune, M.D., S. J. Greene, M.D., P. R. Lichtenthal, M.D.

Anesthesiology. September 1988: 69(3A):A260

https://doi.org/10.1097/00000542-198809010-00259

Published: September 1988

View article

NARROW

Protamine Dosing for Heparin Reversal after Cardiopulmonary Bypass: A Double-blinded Prospective Randomized Control Trial Comparing Two Strategies

Anticoagulation Monitoring for Perioperative Physicians

Factor XII Deficiency and Cardiopulmonary Bypass : Use of a Novel Modification of the Activated Clotting Time to Monitor Anticoagulation

Normal Activated Clotting Time Despite Adequate Anticoagulation with Ancrod in a Patient with Heparin-associated Thrombocytopenia and Thrombosis Undergoing Cardiopulmonary Bypass

ACTIVATED CLOTTING TIME MEASUREMENTS: HOW MUCH WASTE SHOULD BE DRAWN FROM A CONTINUOUSLY FLUSHED-HEPARINIZED LINE TO INSURE ACCURATE RESULTS?

Email alerts

Protamine Dosing for Heparin Reversal after Cardiopulmonary Bypass: A Double-blinded Prospective Randomized Control Trial Comparing Two Strategies

Anticoagulation Monitoring for Perioperative Physicians

Factor XII Deficiency and Cardiopulmonary Bypass : Use of a Novel Modification of the Activated Clotting Time to Monitor Anticoagulation

Normal Activated Clotting Time Despite Adequate Anticoagulation with Ancrod in a Patient with Heparin-associated Thrombocytopenia and Thrombosis Undergoing Cardiopulmonary Bypass

ACTIVATED CLOTTING TIME MEASUREMENTS: HOW MUCH WASTE SHOULD BE DRAWN FROM A CONTINUOUSLY FLUSHED-HEPARINIZED LINE TO INSURE ACCURATE RESULTS?

Email alerts

This Feature Is Available To Subscribers Only